By Apoorva Mandavilli As the coronavirus morphs into a stubborn and unpredictable facet of everyday life, scientists and federal health officials are converging on a new strategy for immunizing Americans: a vaccination campaign this fall, perhaps with doses that are...
Pfizer COVID-19 Vaccine Associated with Dramatic Decline in Antibody Protection Just Weeks After 2nd & 3rd Dose
Danish physicians and scientists affiliated with that Nordic nation's prestigious Statens Serum Institut in Copenhagen and Zealand University Hospital in Naestved report that a study involving 128 patients published in the peer-reviewed JAMA Network Open reveals a...
Pfizer’s Covid Vaccine Protection Against Omicron Fades Just Weeks After Second And Third Doses, Study Finds
By Robert Hart Immunity against the omicron coronavirus variant fades rapidly after a second and third dose of Pfizer and BioNTech’s Covid-19 vaccine, according to peer reviewed research published in JAMA Network Open on Friday, a finding that could...
FDA puts strict limits on Johnson & Johnson Covid-19 vaccine
By Katherine Dillinger The US Food and Drug Administration announced Thursday that it is limiting the emergency use authorization of the Johnson & Johnson/Janssen Covid-19 vaccine to people 18 and older for whom other vaccines aren’t appropriate or accessible and...
Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine
By Karen J. Hager, M.Sc., et al. Abstract BACKGROUND Coronavirus-like particles (CoVLP) that are produced in plants and display the prefusion spike glycoprotein of the original strain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are combined with an...
In interview, Sen. Johnson says it ‘may be true’ that COVID vaccines cause AIDS
BY: HENRY REDMAN In a video interview published on the right-wing social media platform Rumble, Sen. Ron Johnson said it “may be true” that vaccines against COVID-19 cause AIDS. Johnson was being interviewed by anti-vaccine lawyer Todd Callender, who...
Moderna expects ‘large amounts’ of omicron booster available by fall
BY MONIQUE BEALS Moderna’s Chief Medical Officer Paul Burton said on Sunday that his company was preparing to provide large amounts of its vaccine booster against omicron and other COVID-19 variants this fall. “We’re confident by the fall of this year we should...
Troops allege military’s COVID vaccine mandate is a ‘religious purge’
By Meghann Myers Three active duty service members appeared in a segment aired Thursday on a podcast hosted by Rep. Matt Gaetz, R-Florida, accusing the Defense Department of using the COVID-19 vaccine mandate to “intentionally purge” religious service members....
What an Unvaccinated Sergeant Who Nearly Died of Covid Wants You to Know
Frank Talarico, a 47-year-old police sergeant, was hospitalized for 49 days with the coronavirus. “If I was vaccinated,” he said, “I have to think I wouldn’t have gotten as sick as I did.” By Tracey Tully No one thought Frank Talarico Jr. was going to live. Not his...
COVID-19 Third Dose Vaccine Protection Against Hospitalization Wanes After 3 Months
By KAISER PERMANENTE A research study released on April 22, 2022, in The Lancet Respiratory Medicine shows that a booster dose of the Pfizer COVID-19 vaccine provides strong protection, roughly 80% to 90%, in the first few months against hospital...
The Drive to Vaccinate the World Against Covid Is Losing Steam
Rates are stalling in most low-income countries well short of the W.H.O.’s goal to immunize 70 percent of people in every nation. Some public health experts believe the momentum is gone forever. By Rebecca Robbins and Stephanie Nolen In the middle of last year, the...
For mRNA, Covid Vaccines Are Just the Beginning
With clinical vaccine trials for everything from HIV to Zika, messenger RNA could transform medicine—or widen health care inequalities. By AMIT KATWALA KATALIN KARIKÓ NEVER intended to make vaccines. For years before the pandemic, the Hungarian-American...
Why we can’t ‘boost’ our way out of the COVID-19 pandemic for the long term
By Prakash Nagarkatti With yet another COVID-19 booster available for vulnerable populations in the U.S., many people find themselves wondering what the end game will be. The mRNA vaccines currently used in the U.S. against COVID-19 have been highly...
Covid-19 Boosters — Where from Here?
By Paul A. Offit, M.D. On December 10, 2020, Pfizer presented results from a 36,000-person, two-dose, prospective, placebo-controlled trial of its Covid-19 messenger RNA (mRNA) vaccine, BNT162b2, to the Food and Drug Administration (FDA).1 The vaccine was 95%...
Gridiron’s Heavily-Vaxxed Dinner Turns into Breakthrough Super-Spreader Event While Analyst Questions Pfizer’s Vaccine Sales Forecast
While the COVID-19 vaccines have reduced the number of severe infections and deaths, they haven’t stopped viral transmission. This past weekend, mainstream media now reports, a big elite get-together involving top journalists, the Gridiron Dinner in...